A European Registry Study to Prospectively Observe Treatment Patterns and Outcomes in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Unresectable Locally Advanced (LA) or Metastatic Breast Cancer (mBC) (SAMANTHA)
Clinical trial NCT02913456 · COMPLETED
Trial details
- NCT number
- NCT02913456
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-11-16
- Primary completion
- 2024-01-31
- Enrollment
- 629
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.